XBiotech Inc (XBIT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $59.76M
Last updated: Nov 17, 2026 at 4:10 PM ET
XBiotech Inc (XBIT) Stock Chart
XBiotech (XBIT) has a latest price of $1.78 on Nov 17, 2026. Its price fell 32.6% over the past 12 months. The month-end price fell 85.8% over the 10 years through Oct 2026, a compound annual decline of 17.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $22.41 in Jan 2020 and its lowest $1.88 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart XBIT with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for XBIT.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 22.9%, and over 6 months it fell 24.9%. The month-end price fell 55.0% over the 3 years through Oct 2026, a compound annual decline of 23.4%.
| Period | Change |
|---|---|
| 1 month | -11.0% |
| 3 months | -22.9% |
| 6 months | -24.9% |
| 12 months | -32.6% |
| 12 months, with dividends | -32.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -55.0% | -23.4% |
| 5 years | -87.2% | -33.7% |
| 10 years | -85.8% | -17.7% |
Price by Year
Its best calendar year was 2019, when the price rose 267.4%, and its weakest was 2022, when it fell 68.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.88 | -21.3% |
| 2025 | $2.39 | -39.5% |
| 2024 | $3.95 | -1.2% |
| 2023 | $4.00 | +14.0% |
| 2022 | $3.51 | -68.5% |
| 2021 | $11.13 | -28.9% |
| 2020 | $15.65 | -16.2% |
| 2019 | $18.66 | +267.4% |
| 2018 | $5.08 | +28.9% |
| 2017 | $3.94 | -61.1% |
Trading Range
The price is 14.0% below its 50-day average of $2.07 and 22.1% below its 200-day average of $2.28.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.78 | |
| 50-day average | $2.07 | -14.0% |
| 200-day average | $2.28 | -22.1% |
Price Risk
Over 3 years, its largest fall from a peak was 82.0%.
| Measure | Value |
|---|---|
| 1-year beta | 0.50 |
| Largest fall, 1 year | -34.3% |
| Largest fall, 3 years | -82.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About XBIT
What is XBIT's 1-year price change?
XBiotech's price fell 32.6% over the past 12 months. With dividends included, the 12-month total return was -32.6%.
What is XBIT's 5-year price change?
XBiotech's month-end price fell 87.2% over the 5 years through Oct 2026, a compound annual decline of 33.7%. These figures leave out dividends.
What is XBIT's beta?
XBiotech's 1-year beta against the S&P 500 is 0.50, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 34.3%.
Is the XBIT chart free?
Yes. Advanced Charting for XBIT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
XBIT pages: Overview, Charting, Earnings, Financials, Statistics, Competitors